Literature DB >> 12089234

Treatment side effects. Case 2. Toxic, epidermal, necrolysis-like reaction associated with docetaxel chemotherapy.

S P Dourakis1, V A Sevastianos, A Alexopoulou, M Deutsch, N Stavrianeas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12089234     DOI： 10.1200/JCO.2002.20.13.3030

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

2.  Life-threatening dermatologic adverse events in oncology.

Authors:  Alyx C Rosen; Yevgeniy Balagula; Dennis W Raisch; Vishvas Garg; Beatrice Nardone; Nicole Larsen; Jennifer Sorrell; Dennis P West; Milan J Anadkat; Mario E Lacouture
Journal:  Anticancer Drugs       Date:  2014-02       Impact factor: 2.248

Review 3.  Anticancer Drugs Induced Severe Adverse Cutaneous Drug Reactions: An Updated Review on the Risks Associated with Anticancer Targeted Therapy or Immunotherapies.

Authors:  Chau Yee Ng; Chun-Bing Chen; Ming-Ying Wu; Jennifer Wu; Chih-Hsun Yang; Rosaline Chung-Yee Hui; Ya-Ching Chang; Chun-Wei Lu
Journal:  J Immunol Res       Date:  2018-01-17       Impact factor: 4.818

4.  Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma.

Authors:  Osama Diab; Dan Mcentire; Thamer Kassim; Ali Nayfeh; Abdel Rahman Dajani; Mitchell Kerfeld; Jonathon Campbell; Adbullah Alsuwaidan; Mahmoud Abu Hazeem; Maryam Gbadamosi-Akindele
Journal:  Case Rep Oncol Med       Date:  2019-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.